Research Reports

All CHPA manufacturer members (62 in total) were asked to participate in the first survey of diversity, equity, and inclusion in the industry. The survey was conducted from March – July 2022.

The Medicare Advantage health insurance market represents an attractive and rapidly growing opportunity in the Consumer Healthcare and OTC Medicines industry.

Consumer self-care changed during the COVID-19 pandemic. This report from IRI and CHPA divides consumers into seven distinct segments and discussed how CPGs and retailers can reach them with the right health and wellness solutions.

CHPA’s “Insights with Impact” series features Cindy Sanders, Co-Publisher/Managing Editor of Nashville Medical News, who discusses the growing interest in over-the-counter access to oral contraceptives.

List of laws by state summarizing sales restrictions of dextromethorphan to minors.

This update includes any new statutes or laws passed in states regarding CBD labeling laws, as well as including any regulatory standards regarding CBD labeling laws in those states from spring to fall 2020.

State by state listing of restrictions and regulations concerning distribution of OTC product samples.

State by state listing of what entities are permitted to alter controlled substance schedules.

This document describes the types of regulations dietitians and nutritionists must adhere to in each state.

The authority to sell nonprescription drugs in vending machines is determined by the Food and Drug Administration (FDA), state by state specific legislation, and sanctioned state regulatory bodies.